Capital Accumulation

Cambrex and AstraZeneca kick off manufacturing agreement

16-Jan-2018 By Melissa Fassbender

Cambrex and AstraZeneca have commenced a long-term manufacturing agreement with an opening ceremony at the CDMO’s site in Sweden.

Avista doubles API capacity in Colorado

14-Nov-2017 By Dan Stanton

Avista Pharma has added a fourth GMP suite at its Longmont facility as part of an investment of more than $20m in its manufacturing operations.

CordenPharma ups Swiss API development services

16-Oct-2017 By Staff Reporter

CordenPharma has invested in its Swiss API development services a week after buying a manufacturing plant from Pfizer.

Idifarma adds contract capsule filling to offering

18-Jul-2017 By Staff Reporter

Idifarma has bolstered its capsule filling capabilities at its manufacturing plant in Pamplona, Spain.

Cambrex continues to up capacity with more than $200m invested in 5 years

31-May-2017 By Melissa Fassbender

Cambrex Corporation has increased new capacity at its Sweden-based cGMP as the manufacturer focuses on market demand and customer need, says VP.

Avista completes $4m facility expansion at former Microtest Labs

27-Mar-2017 By Melissa Fassbender

The expanded facility features an additional 4,200 square feet of space to enhance its microbiology, sterility testing, and microbial ID service offerings.

PCI ups cryogenic storage capacity at Rockford site by 400%

27-Mar-2017 By Melissa Fassbender

PCI Clinical Services (PCI) has announced a second 400% increase in cryogenic storage capabilities as it looks to support “considerable growth.”

Molecular Profiles' investment makes HME (bio)available for clients

08-Apr-2014 By Dan Stanton

Molecular Profiles has invested in hot melt extrusion (HME) and nano milling capabilities citing client demand for improving the bioavailablity of drugs.

Bend expands SDD services with $20m Capsugel capital injection

11-Nov-2013 By Dan Stanton

Bend Research is expanding its commercial spray-dried dispersion (SDD) manufacturing with capital from new owners Capsugel in order to offer unique integrated capabilities, the firm says.

Vetter invests $100m to keep filling services ahead of the game

10-Oct-2013 By Dan Stanton

Vetter says plans for a $100m (€74m) expansion are driven by continued growth in the biopharma industry and keep the firm one step “ahead of the curve.”

Recipharm adds analytical capacity at Swedish plant

04-Dec-2012

Swedish CMO Recipharm has added capacity for analytical services and stability studies at its laboratory in Solna, Sweden

Piramal expands ADC capacity predicting market growth

03-Nov-2011 By Gareth Macdonald

Piramal Healthcare has added commercial-scale antibody-drug-conjugate (ADC) manufacturing capacity at its UK plant predicting increasing demand for this specialist type of contracting.